UPDATE: Phibro Animal Health (PAHC) Tops Q2 EPS by 6c, Offers FY Guidance

Phibro Animal Health (NASDAQ: PAHC) reported Q2 EPS of $0.34, $0.06 better than the analyst estimate of $0.28. Revenue for the quarter came in at $214 million versus the consensus estimate of $218.89 million.

Guidance:

Company sees FY20 EPS of $1.15-$1.22 vs $1.11 consensus on revenue of $812-$828 million vs $$838.1 million consensus.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• FirstCash to acquire UK pawn operator Ramsdens for £206 million
• Bernstein SocGen Group Upgrades X-Fab Silicon Foundries SE (XFAB:FP) to Outperform